Status:
COMPLETED
Exploratory Study of Volatile Organic Compounds in Alveolar Breath
Lead Sponsor:
Mebo Research, Inc.
Collaborating Sponsors:
Menssana Research, Inc.
Aurametrix
Conditions:
Nutritional and Metabolic Diseases
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this secondary analysis is to identify breath signatures associated with idiopathic malodor conditions.
Detailed Description
Individuals with metabolic disorders may sporadically produce malodors despite good hygiene. Analysis of volatile organic compounds (VOCs) helps to gain insights into medical conditions arising due to...
Eligibility Criteria
Inclusion
- good general health
- willing and able to travel to one of the participating sites
Exclusion
- medical conditions that, in the opinion of the investigator, would prevent participation
- elect not to participate in the study
Key Trial Info
Start Date :
October 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 11 2020
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT03451994
Start Date
October 1 2011
End Date
October 11 2020
Last Update
October 14 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
MeBO Research
Miami, Florida, United States, 33175
2
MeBO Research LTD
London, England, United Kingdom, W10 5LE